Fentanyl Global Market Report 2025

Description

Fentanyl is a synthetic opioid known for its high potency and is commonly used for pain relief and anesthesia purposes. Physicians prescribe fentanyl to manage severe pain, particularly post-surgery and in advanced-stage cancer patients. Fentanyl is available in the form of transdermal patches or lozenges.

The primary types of fentanyl include fentanyl injections and fentanyl TTS (transdermal therapeutic system). Fentanyl injections are a medication delivery method that administers the opioid directly into the bloodstream. These injections are primarily employed to alleviate severe pain during and after surgical procedures. Fentanyl is utilized for various applications, including anesthesia, maintaining anesthesia, general analgesia, postoperative analgesia, and managing breakthrough cancer pain. The recipients of fentanyl treatment include hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.

The fentanyl market research report is one of a series of new reports from The Business Research Company that provides fentanyl market statistics, including fentanyl industry global market size, regional shares, competitors with a fentanyl market share, detailed fentanyl market segments, market trends and opportunities, and any further data you may need to thrive in the fentanyl industry. This fentanyl market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fentanyl market size has grown strongly in recent years. It will grow from $16.22 billion in 2024 to $17.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to pain management needs, medical procedures and surgeries, cancer pain management, opioid analgesic market growth, aging population.

The fentanyl market size is expected to see strong growth in the next few years. It will grow to $22.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rise in chronic pain cases, expanding oncology therapies, increasing surgical procedures, public health initiatives, regulatory approval for new indications. Major trends in the forecast period include technological advancements in drug formulations, technological innovations in detection, public health and harm reduction strategies, rise in pharmaceutical applications, international collaboration and information sharing.

The rising prevalence of chronic diseases is anticipated to drive the growth of the fentanyl market in the future. Chronic diseases are medical conditions that last for an extended period, typically three months or longer, and often persist throughout a person's life. Fentanyl is primarily used in chronic disease management to alleviate severe, persistent pain that other treatments or medications do not adequately control. For example, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported in their Heart Disease Facts that coronary heart disease (CHD) was responsible for 371,506 deaths in the United States in 2022, contributing to a total of 702,880 deaths from heart disease, which accounted for roughly 1 in every 5 deaths. Consequently, the increasing prevalence of chronic diseases is fueling the growth of the fentanyl market.

The growing demand for pain management is projected to propel the growth of the fentanyl market in the coming years. Pain management is a medical field dedicated to alleviating pain and enhancing the quality of life for patients. Fentanyl is a powerful opioid that provides effective pain relief, particularly for individuals experiencing severe or chronic pain, by reducing pain levels, improving physical functioning, and addressing the root causes of pain. For instance, in May 2022, the Pain Relief Foundation, a UK-based charity, reported that arthritis and musculoskeletal conditions affect over 17 million people in the UK, leading to 30 million lost working days each year, while chronic pain impacts up to 62% of individuals over the age of 75, highlighting the increasing burden of pain in an aging population. Therefore, the rising demand for pain management is driving the growth of the fentanyl market.

Leading companies in the fentanyl market are actively innovating by developing groundbreaking products such as Opvee, securing regulatory approvals to expand their customer base, drive higher sales, and achieve increased revenue. Opvee, also known as nalmefene, serves as a potent opioid receptor blocker specifically designed for treating confirmed or suspected opioid overdose induced by natural or synthetic opioids, including fentanyl. An illustrative example is the accomplishment of Indivior PLC, a prominent U.S.-based pharmaceutical company, which obtained approval from the U.S. Food and Drug Administration for Opvee nasal spray in May 2023. This nasal spray operates by averting the impact of opioids on the brain, aiding patients recently subjected to overdose in restoring normal respiration and blood pressure. The convenience of administering Opvee as a nasal spray enhances its effectiveness during emergency situations, contributing significantly to the arsenal of medications combating opioid overdoses and saving lives.

In April 2023, SK Capital Partners LP, a distinguished U.S.-based private investment company, successfully completed the acquisition of Apotex Pharmaceutical Holdings Inc. This transaction, executed for an undisclosed amount, is geared towards diversifying Apotex's product portfolio, positioning it as a Canadian global health firm, and leveraging its proficiency in producing cost-effective drugs. Apotex Pharmaceutical Holdings Inc., headquartered in Canada, specializes in the manufacturing of fentanyl transdermal systems. This strategic acquisition underscores SK Capital Partners LP's commitment to strengthening its presence in the pharmaceutical industry while enhancing its capabilities and offerings.

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fentanyl market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The fentanyl market consists of sales of fentanyl patch, fentanyl lozenge, fentanyl nasal spray, fentanyl sublingual spray, fentanyl sublingual tablets, fentanyl lollipop, and fentanyl film. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fentanyl Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fentanyl market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fentanyl ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fentanyl market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Fentanyl Injections; Fentanyl TTS (Transdermal Therapeutic System)
2) By Application: Inducting Anesthesia; Maintain Anesthesia; General Analgesic; Postoperative Analgesia; Breakthrough Cancer Pain
3) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Fentanyl Injections: Injectable Solutions; Premixed Injection Formulations
2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations; Matrix Patch Systems
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Sinopharm Group; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28081

1. Executive Summary

2. Fentanyl Market Characteristics

3. Fentanyl Market Trends And Strategies

4. Fentanyl Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fentanyl Growth Analysis And Strategic Analysis Framework

5.1. Global Fentanyl PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Fentanyl Market Growth Rate Analysis
5.4. Global Fentanyl Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Fentanyl Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Fentanyl Total Addressable Market (TAM)

6. Fentanyl Market Segmentation

6.1. Global Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fentanyl Injections
Fentanyl TTS (Transdermal Therapeutic System)
6.2. Global Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inducting Anesthesia
Maintain Anesthesia
General Analgesic
Postoperative Analgesia
Breakthrough Cancer Pain
6.3. Global Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
Other End Users
6.4. Global Fentanyl Market, Sub-Segmentation Of Fentanyl Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Solutions
Premixed Injection Formulations
6.5. Global Fentanyl Market, Sub-Segmentation Of Fentanyl TTS (Transdermal Therapeutic System), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Patch Formulations
Matrix Patch Systems

7. Fentanyl Market Regional And Country Analysis

7.1. Global Fentanyl Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Fentanyl Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fentanyl Market

8.1. Asia-Pacific Fentanyl Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fentanyl Market

9.1. China Fentanyl Market Overview
9.2. China Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fentanyl Market

10.1. India Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fentanyl Market

11.1. Japan Fentanyl Market Overview
11.2. Japan Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fentanyl Market

12.1. Australia Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fentanyl Market

13.1. Indonesia Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fentanyl Market

14.1. South Korea Fentanyl Market Overview
14.2. South Korea Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fentanyl Market

15.1. Western Europe Fentanyl Market Overview
15.2. Western Europe Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fentanyl Market

16.1. UK Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fentanyl Market

17.1. Germany Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fentanyl Market

18.1. France Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fentanyl Market

19.1. Italy Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fentanyl Market

20.1. Spain Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fentanyl Market

21.1. Eastern Europe Fentanyl Market Overview
21.2. Eastern Europe Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fentanyl Market

22.1. Russia Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fentanyl Market

23.1. North America Fentanyl Market Overview
23.2. North America Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fentanyl Market

24.1. USA Fentanyl Market Overview
24.2. USA Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fentanyl Market

25.1. Canada Fentanyl Market Overview
25.2. Canada Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fentanyl Market

26.1. South America Fentanyl Market Overview
26.2. South America Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fentanyl Market

27.1. Brazil Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fentanyl Market

28.1. Middle East Fentanyl Market Overview
28.2. Middle East Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fentanyl Market

29.1. Africa Fentanyl Market Overview
29.2. Africa Fentanyl Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Fentanyl Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Fentanyl Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fentanyl Market Competitive Landscape And Company Profiles

30.1. Fentanyl Market Competitive Landscape
30.2. Fentanyl Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sinopharm Group Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Fentanyl Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Kyowa Kirin Co. Ltd.
31.3. Fresenius Kabi Oncology Ltd.
31.4. Abbott Laboratories
31.5. Sanofi S.A
31.6. Boehringer Ingelheim GmbH
31.7. Viatris Inc.
31.8. Baxter International Inc.
31.9. Teva Pharmaceutical Industries Limited
31.10. Jiangsu Nhwa Pharmaceutical Co. Ltd.
31.11. Cephalon LLC
31.12. AstraZeneca plc
31.13. Apotex Inc.
31.14. Hisamitsu Pharmaceutical Co. Inc.
31.15. Alvogen

32. Global Fentanyl Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fentanyl Market

34. Recent Developments In The Fentanyl Market

35. Fentanyl Market High Potential Countries, Segments and Strategies

35.1 Fentanyl Market In 2029 - Countries Offering Most New Opportunities
35.2 Fentanyl Market In 2029 - Segments Offering Most New Opportunities
35.3 Fentanyl Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer